Enlarged hypothalamic volumes in schizophrenia

Psychiatry Research - Neuroimaging

Volumn 204, Issue 2-3, 2012, Pages 75-81

  Tognin, Stefania ^a,b   Rambaldelli, Gianluca ^b   Perlini, Cinzia ^b   Bellani, Marcella ^b   Marinelli, Veronica ^b   Zoccatelli, Giada ^c   Alessandrini, Franco ^c   Pizzini, Francesca Benedetta ^c   Beltramello, Alberto ^c   Terlevic, Robert ^d   Tansella, Michele ^b   Balestrieri, Matteo ^e   Brambilla, Paolo ^d,e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY HOSPITAL OF VERONA   (Italy)

^d SCIENTIFIC INSTITUTE   (Italy)

^e UNIVERSITY OF UDINE   (Italy)

Author keywords

Hypothalamic pituitary adrenal axis; Hypothalamus; Mammillary bodies; MRI; Schizophrenia; Volume

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

ADULT; ANXIETY; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOTHALAMUS; MALE; MAMMILLARY BODY; NEGATIVE SYNDROME; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; FEMALE; HUMANS; HYPOTHALAMUS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; STATISTICS AS TOPIC;

EID: 84872400451     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2012.10.006     Document Type: Article

References (60)

1. Akhondzadeh S., Rezaei F., Larijani B., Nejatisafa A.A., Kashani L., Abbasi S.H. Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia. Schizophrenia Research 2006, 84:405-410.
2. Amaddeo F., Burti L., Ruggeri M., Tansella M. Long-term monitoring and evaluation of a new system of community-based psychiatric care. Integrating research, teaching and practice at the University of Verona. Annali dell'Istituto Superiore di Sanita' 2009, 45:43-53.
3. Amaddeo F., Tansella M. Information systems for mental health. Epidemiologia e Psichiatria Sociale 2009, 18:1-4.
4. Bao A.M., Hestiantoro A., Van Someren E.J., Swaab D.F., Zhou J.N. Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders. Brain 2005, 128:1301-1313.
5. Beckmann H., Lang R.E., Gattaz W.F. Vasopressin-oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls. Psychoneuroendocrinology 1985, 10:187-191.
6. Beltramino C., Taleisnik S. Inhibitory influence of the nuclei of the posterior hypothalamus on the pro-oestrous surge of LH. Acta Endocrinologica 1984, 105:433-440.
7. Belvederi Murri M., Pariante C.M., Dazzan P., Hepgul N., Papadopoulos A.S., Zunszain P., et al. Hypothalamic-pituitary-adrenal axis and clinical symptoms in first-episode psychosis. Psychoneuroendocrinology 2012, 37:629-644.
8. Ben-Jonathan N., Hnasko R. Dopamine as a prolactin (PRL) inhibitor. Endocrine Reviews 2001, 22:724-763.
9. Beracochea D.J., Krazem A. Effects of mammillary body and mediodorsal thalamic lesions on elevated plus maze exploration. Neuroreport 1991, 2:793-796.
10. Bergemann N., Mundt C., Parzer P., Jannakos I., Nagl I., Salbach B., et al. Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics. Schizophrenia Research 2005, 73:357-366.
11. Bernstein H.G., Keilhoff G., Steiner J., Dobrowolny H., Bogerts B. The hypothalamus in schizophrenia research: no longer a wallflower existence. The Open Neuroendocrinology Journal 2010, 3:59-67.
12. Bernstein H.G., Krause S., Krell D., Dobrowolny H., Wolter M., Stauch R., et al. Strongly reduced number of parvalbumin-immunoreactive projection neurons in the mammillary bodies in schizophrenia: further evidence for limbic neuropathology. Annals of the New York Academy of Sciences 2007, 1096:120-127.
13. Briess D., Cotter D., Doshi R., Everall I. Mamillary body abnormalities in schizophrenia. Lancet 1998, 352:789-790.
14. Cookson J., Hodgson R., Wildgust H.J. Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis. Journal of Psychopharmacology 2012, 26:42-51.
15. Coppen A., Abou-Saleh M., Milln P., Metcalfe M., Harwood J., Bailey J. Dexamethasone suppression test in depression and other psychiatric illness. British Journal of Psychiatry 1983, 142:498-504.
16. Corcoran C., Walker E., Huot R., Mittal V., Tessner K., Kestler L., et al. The stress cascade and schizophrenia: etiology and onset. Schizophrenia Bulletin 2003, 29:671-692.
17. First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W., 2000. SCID-I. Interviste Cliniche Strutturate per il DSM-IV.
18. Garner B., Pariante C.M., Wood S.J., Velakoulis D., Phillips L., Soulsby B., et al. Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biological Psychiatry 2005, 58:417-423.
19. Goldstein J.M., Seidman L.J., Makris N., Ahern T., O'Brien L.M., Caviness V.S., et al. Hypothalamic abnormalities in schizophrenia: sex effects and genetic vulnerability. Biological Psychiatry 2007, 61:935-945.
20. Ho B.C., Andreasen N.C., Ziebell S., Pierson R., Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Archives of General Psychiatry 2011, 68:128-137.
21. Hurlemann R., Jessen F., Wagner M., Frommann I., Ruhrmann S., Brockhaus A., et al. Interrelated neuropsychological and anatomical evidence of hippocampal pathology in the at-risk mental state. Psychological Medicine 2008, 38:843-851.
22. Kaneko M., Yokoyama F., Hoshino Y., Takahagi K., Murata S., Watanabe M., et al. Hypothalamic-pituitary-adrenal axis function in chronic schizophrenia: association with clinical features. Neuropsychobiology 1992, 25:1-7.
23. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
24. Kienast T., Heinz A. Dopamine and the diseased brain. CNS and Neurological Disorders Drug Targets 2006, 5:109-131.
25. Kim J.H., Tien R.D., Felsberg G.J., Osumi A.K., Lee N. Clinical significance of asymmetry of the fornix and mamillary body on MR in hippocampal sclerosis. American Journal of Neuroradiology 1995, 16:509-515.
26. Klomp A., Koolschijn P.C., Hulshoff Pol H.E., Kahn R.S., Van Haren N.E. Hypothalamus and pituitary volume in schizophrenia: a structural MRI study. The International Journal of Neuropsychopharmacology 2011, 1-8.
27. Koolschijn P.C., van Haren N.E., Hulshoff Pol H.E., Kahn R.S. Hypothalamus volume in twin pairs discordant for schizophrenia. European Neuropsychopharmacology 2008, 18:312-315.
28. Markham, J.A., 2011. Sex steroids and schizophrenia. Reviews in Endocrine and Metabolic Disorders.
29. Mondelli V., Dazzan P., Hepgul N., Di Forti M., Aas M., D'Albenzio A., et al. Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment. Schizophrenia Research 2010, 116:234-242.
30. Norman R.M., Malla A.K. Stressful life events and schizophrenia I: a review of the research. British Journal of Psychiatry 1993, 162:161-166.
31. Ozturk A., Yousem D.M., Mahmood A., El Sayed S. Prevalence of asymmetry of mamillary body and fornix size on MR imaging. American Journal of Neuroradiology 2008, 29:384-387.
32. Pacak K., Palkovits M., Kopin I.J., Goldstein D.S. Stress-induced norepinephrine release in the hypothalamic paraventricular nucleus and pituitary-adrenocortical and sympathoadrenal activity: in vivo microdialysis studies. Frontiers in Neuroendocrinology 1995, 16:89-150.
33. Pariante C.M. Pituitary volume in psychosis: the first review of the evidence. Journal of Psychopharmacology 2008, 22:76-81.
34. Pariante C.M., Vassilopoulou K., Velakoulis D., Phillips L., Soulsby B., Wood S.J., et al. Pituitary volume in psychosis. British Journal of Psychiatry 2004, 185:5-10.
35. Riecher-Rossler A., Hafner H., Stumbaum M., Maurer K., Schmidt R. Can estradiol modulate schizophrenic symptomatology?. Schizophrenia Bulletin 1994, 20:203-214.
36. Riecher-Rossler A., Kulkarni J. Estrogens and gonadal function in schizophrenia and related psychoses. Current Topics in Behavioral Neuroscience 2011, 8:155-171.
37. Ryan M.C., Sharifi N., Condren R., Thakore J.H. Evidence of basal pituitary-adrenal overactivity in first episode, drug naive patients with schizophrenia. Psychoneuroendocrinology 2004, 29:1065-1070.
38. Sachar E.J., Kanter S.S., Buie D., Engle R., Mehlman R. Psychoendocrinology of ego disintegration. American Journal of Psychiatry 1970, 126:1067-1078.
39. Sapolsky R.M. Stress and plasticity in the limbic system. Neurochemical Research 2003, 28:1735-1742.
40. Shibata K., Kataoka Y., Yamashita K., Ueki S. An important role of the central amygdaloid nucleus and mammillary body in the mediation of conflict behavior in rats. Brain Research 1986, 372:159-162.
41. Smith S., Wheeler M.J., Murray R., O'Keane V. The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis. Journal of Clinical Psychopharmacolgy 2002, 22:109-114.
42. Steen R.G., Mull C., McClure R., Hamer R.M., Lieberman J.A. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. British Journal of Psychiatry 2006, 188:510-518.
43. Suarez M., Perassi N.I. Plasma corticosterone responses to lesions and stimulations of the limbic thalami nuclei, medial mammillary nucleus and cingulate cortex. Archives Internationales de Physiologie et de Biochime 1988, 96:69-74.
44. Sullivan G., Lukoff D. Sexual side effects of antipsychotic medication: evaluation and interventions. Hospital and Community Psychiatry 1990, 41:1238-1241.
45. Swaab D.F. Human hypothalamus: basic and clinical aspects part II: neuropathology of the hypothalamus and adjacent brain structures. Handbook of Clinical Neurology 2004, Elsevier, Amsterdam. M.J. Aminoff, F. Boller, D.F. Swaab (Eds.).
46. Swaab D.F., Fliers E. A sexually dimorphic nucleus in the human brain. Science 1985, 228:1112-1115.
47. Sziklas V., Petrides M. Memory and the region of the mammillary bodies. Progress in Neurobiology 1998, 54:55-70.
48. Takahashi T., Suzuki M., Velakoulis D., Lorenzetti V., Soulsby B., Zhou S.Y., et al. Increased pituitary volume in schizophrenia spectrum disorders. Schizophrenia Research 2009, 108:114-121.
49. Tandon R., Mazzara C., DeQuardo J., Craig K.A., Meador-Woodruff J.H., Goldman R., et al. Dexamethasone suppression test in schizophrenia: relationship to symptomatology, ventricular enlargement, and outcome. Biological Psychiatry 1991, 29:953-964.
50. Tansella M., Amaddeo F., Burti L., Lasalvia A., Ruggeri M. Evaluating a community-based mental health service focusing on severe mental illness. The Verona experience. Acta Psychiatrica Scandinavica Supplementum 2006, 90-94.
51. Tansella M., Burti L. Integrating evaluative research and community-based mental health care in Verona, Italy. British Journal of Psychiatry 2003, 183:167-169.
52. Tomelleri L., Jogia J., Perlini C., Bellani M., Ferro A., Rambaldelli G., et al. Brain structural changes associated with chronicity and antipsychotic treatment in schizophrenia. European Neuropsychopharmacology 2009, 19:835-840.
53. Tournikioti K., Tansella M., Perlini C., Rambaldelli G., Cerini R., Versace A., et al. Normal pituitary volumes in chronic schizophrenia. Psychiatry Research Neuroimaging 2007, 154:41-48.
54. Velakoulis D., Wood S.J., Wong M.T., McGorry P.D., Yung A., Phillips L., et al. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Archives of General Psychiatry 2006, 63:139-149.
55. Vyas A., Mitra R., Shankaranarayana Rao B.S., Chattarji S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. The Journal of Neuroscience 2002, 22:6810-6818.
56. Walker E., Mittal V., Tessner K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annual Review of Clinical Psychology 2008, 4:189-216.
57. Walker E.F., Diforio D. Schizophrenia: a neural diathesis-stress model. Psychological Review 1997, 104:667-685.
58. Walker E.F., Walder D.J., Reynolds F. Developmental changes in cortisol secretion in normal and at-risk youth. Development and Psychopathology 2001, 13:721-732.
59. Wardle J., Steptoe A., Oliver G., Lipsey Z. Stress, dietary restraint and food intake. Journal of Psychosomatic Research 2000, 48:195-202.
60. Zhang X.Y., Zhou D.F., Cao L.Y., Wu G.Y., Shen Y.C. Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics. Neuropsychopharmacology 2005, 30:1532-1538.